Document is current
Any future updates will be listed below
-
Authors
Haastrup, Peter
Søndergaard, Jens
Bjørsum-Meyer, Thomas
Schelde-Olesen, Benedicte
Baatrup, Gunnar
-
Funding
Funding for this research was provided by:
University of Southern Denmark
- License Information
-
More Information
Article History
Received: 2 April 2024
Accepted: 30 April 2025
First Online: 14 May 2025
Declarations
:
: The feasibility study was carried out in accordance with the Declaration of Helsinki. The study was approved by the Regional Ethics Committee of Southern Denmark, project no. S-20220085. Further, the project was approved by the Research Counsil at Odense University Hospital, ID-no 305-2023-GB. Prior to consenting to participate all GPs and patients were thoroughly informed about the study and that participation was completely voluntary and that they could withdraw from the study at any time without providing an explanation.
: All participants were informed that the project was a research project and that their data would be anonymized so no participant would be identifiable in subsequent publications. All participants (GPs and patients) gave informed consent to participate under these terms.
: Benedicte Schelde-Olesen has received honoraria and participated in advisory board meetings for Jinshan Ltd. Jens Søndergaard has received fees from Abbott Rapid Diagnostics, Roche Diagnostics, Roche, Novo Nordisk A/S, and is member of the board of Steno Diabetes Center, Odense.
